Rapafusyn Pharmaceuticals logo

Rapafusyn Pharmaceuticals Funding & Investors

Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle. The company develops novel pharmaceuticals to treat patients having diseases and fulfill other unmet medical needs.

rapafusyn.com

Total Amount Raised: $28,000,000

Rapafusyn Pharmaceuticals Funding Rounds

  • Series A

    $28,000,000

    Series A Investors

    3E Bioventures Capital
    Proxima Ventures
    Lapam Capital
Funding info provided by Diffbot.